Cash & equivalents increased 51.4%
Cash & equivalents changed +51.4% from the comparable as-filed period. The change ranks at the 100th percentile of 4 prior comparable changes.
Ranked by interpretable importance, issuer history, magnitude, and accounting profile. No directional recommendation.
Cash & equivalents changed +51.4% from the comparable as-filed period. The change ranks at the 100th percentile of 4 prior comparable changes.
Gross profit changed -96.5% from the comparable as-filed period. The change ranks at the 75th percentile of 4 prior comparable changes.
Inventory changed -46.3% from the comparable as-filed period. The change ranks at the 75th percentile of 4 prior comparable changes.
Net income changed +53.5% from the comparable as-filed period.
Operating income changed +53.8% from the comparable as-filed period. The change ranks at the 75th percentile of 4 prior comparable changes.
Operating margin changed -34377 basis points from the comparable as-filed period. The change ranks at the 75th percentile of 4 prior comparable changes.
Revenue changed -96.6% from the comparable as-filed period. The change ranks at the 75th percentile of 4 prior comparable changes.
Gross margin changed +76 basis points from the comparable as-filed period. The change ranks at the 50th percentile of 4 prior comparable changes.
Research & development changed +8.9% from the comparable as-filed period.
Method Importance combines metric-family relevance, magnitude, issuer-history unusualness, persistence, and financial-statement significance. It is analytical prioritization, not a legal materiality conclusion or investment signal.